American Renal Associates Holdings Inc. (NYSE:ARA) traded up 3.3% during trading on Wednesday . The company traded as high as $24.19 and last traded at $23.51, with a volume of 116,237 shares trading hands. The stock had previously closed at $22.75.

A number of equities research analysts have recently commented on ARA shares. Leerink Swann started coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They set an “outperform” rating and a $33.00 target price on the stock. SunTrust Banks Inc. started coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They set a “buy” rating and a $34.00 target price on the stock. Wells Fargo & Co. started coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They set an “outperform” rating on the stock. Goldman Sachs Group Inc. started coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They set a “neutral” rating and a $30.00 target price on the stock. Finally, Barclays PLC started coverage on shares of American Renal Associates Holdings in a research note on Monday, May 16th. They set an “overweight” rating and a $33.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. American Renal Associates Holdings presently has a consensus rating of “Buy” and a consensus price target of $31.20.

The firm has a market cap of $520.15 million and a PE ratio of 11.93. The firm’s 50-day moving average price is $0.00 and its 200-day moving average price is $0.00.

American Renal Associates Holdings (NYSE:ARA) last posted its quarterly earnings results on Tuesday, August 9th. The company reported ($0.75) EPS for the quarter. The business had revenue of $185.60 million for the quarter, compared to analysts’ expectations of $161.50 million. On average, equities research analysts anticipate that American Renal Associates Holdings Inc. will post $0.88 EPS for the current fiscal year.

American Renal Associates Holdings, Inc is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.